Melbourne Stem Cell Centre believes that Australia is well placed to become a leader in stem cell research. This creates a unique opportunity for Melbourne Stem Cell Centre to become a world leader in osteoarthritis research.
Osteoarthritis is the 4th leading cause of disability across the world. Recognising this, the primary objective for any management strategy is to improve pain and function and thus improve quality of life. Recent improved understanding of the process that leads to joint destruction and joint osteoarthritis means that regenerative therapies such have a real place in the conservative treatment of this disabling condition.
Stem Cell Research
Adult stem cells are found throughout the body. They multiply by cell division to replenish dying cells and regenerate damaged tissues. Scientific interest in adult stem cells is centred on their ability to divide or self-renew indefinitely, and generate all the cell types of the organ from which they originate, potentially regenerating the entire organ from a few cells.
At this stage Melbourne Stem Cell Centre is focused on the treatment of joint osteoarthritis.
Clinical trials enable us to take a laboratory proven concept and thoroughly test and analyse the effectiveness of a treatment. Melbourne Stem Cell Centre trial protocols have prior and retrospective independent Human Research Ethics Committee approval and every patient is strictly followed-up to assess outcome/effectiveness of the treatment undertaken, thus helping treat and modify the disease process occurring osteoarthritis.